3rd Circ. Shuts Down Generic Fosamax Appeal
The Third Circuit on Wednesday upheld a lower court ruling that generic manufacturers of equivalents of the bone drug Fosamax could not be held liable for injuries supposedly incurred by drug...To view the full article, register now.
Already a subscriber? Click here to view full article